Biotechnology - Asia-Pacific, Respiratory and Pulmonary


Popular Filters

Japanese approval for Actelion's epoprostenol "ACT"


Europe's largest biotech firm Actelion (SIX: ATLN) yesterday announced that Japan's Ministry of Health,…

ActelionAsia-PacificBiotechnologyepoprostenol "ACT"RegulationRespiratory and PulmonaryVeletri

New Zealand approves funding of sildenafil for Raynaud's phenomenon and bosentan for children with PAH


New Zealand's Pharmaceutical Management Agency PHARMAC has approved proposals for funding Pfizer's (NYSE:…

ActelionAsia-PacificBiotechnologybosentanFinancialPfizerPharmaceuticalRegulationRespiratory and PulmonaryRevatiosildenafilTracleer

Proposal in relation to Actelion's Tracleer in New Zealand


New Zealand's national pharmaceuticals funding agency PHARMAC is seeking feedback on a proposal in relation…

ActelionAsia-PacificBiotechnologyPricingRegulationRespiratory and PulmonaryTracleer

Back to top